-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
January 01, 2015 - the needs of each client and, depending on the design, could
lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … CCBT=Computer-assisted
cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
November 20, 2014 - TEP Reviewer 2 Introduction 2) page 31/231, Staging, line27-28 “...and may require
neoadjuvant therapy … Peer Reviewer 4 Results Page 29, provide explicit definition of “correct treatment”, “under-
treatment … ” and “over-treatment”. … Report points to intermediate outcomes and defines these as
stage reclassification and changes in therapeutic … In recent
years, innovative, dose-lowering technologies assessing whether
therapeutic interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
January 01, 2016 - arthritis can present with clinically similar signs and
symptoms, but the conditions have different treatments … Part 1: systematic nonpharmacologic and pharmacologic
therapeutic approaches to hyperuricemia. … Part 2: therapy and antiinflammatory prophylaxis of acute gouty
arthritis. … Report of a task
force of the Standing Committee for International Clinical Studies
Including Therapeutics … between gout flares, time in treatment,
serum uric acid level and urate lowering therapy.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
January 10, 2017 - benefits of folic acid supplementation may vary by dosage, timing relative to pregnancy, duration of therapy … Eight fair-quality case-control studies addressed dose, timing, or duration of therapy. 1 Of these 8 … No evidence was found on harms differing by duration of therapy. 1 . … vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics
-
digital.ahrq.gov/sites/default/files/docs/citation/k08hs018538-gesteland-final-report-2014.pdf
January 01, 2014 - Consider the orientation of a
typical ambulatory primary care clinician faced with making diagnostic and treatment … data about their individual practice
patterns and recommendations about diagnosis, prevention, and treatment—provide … The best possible care includes cost effective diagnostic practices and therapeutic
applications that … diagnosing acute respiratory
infections (ARIs), discussing the diagnosis & management of ARI and describing treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
August 13, 2012 - If phase 2 studies show that the drug
has a therapeutic effect and lacks significant
adverse effects … For instance, under this staged approach new
treatments could rapidly diffuse into a market
even when … therapy will lead to the
outcomes of interest and the likelihood that this
conclusion will be affected … On the other hand, a patient who has
a health condition where there are few treatments
may be willing … This panel portrays
health care treatments as providing a large zone of
15
Chapter 1.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
January 01, 2010 - Treatment for hypertension has traditionally been
defined as pharmacological or nonpharmacological
therapy … Pharmacological Treatments
for Adults with Hypertension
Stage 3 Hypertension. … Nonpharmacological Therapies
in Adults
RCTs of nonpharmacological therapies have
examined CVD events … Additionally,
treatment of adult hypertensive patients with drug
therapy and possibly nonpharmacological … New
meta-analysis of treatment trials of hypertension:
improving the estimate of therapeutic benefit.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/high-blood-pressure-adults-children-adolescents-screening-2003
April 01, 2003 - Treatment for hypertension has traditionally been defined as pharmacological or nonpharmacological therapy … Pharmacological Treatments for Adults with Hypertension
Stage 3 Hypertension. … Nonpharmacological Therapies in Adults
RCTs of nonpharmacological therapies have examined CVD events … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
October 01, 2019 - on evidence from
randomized controlled trials (RCTs) as the gold
standard design for evaluating a therapeutic … Pharmacologic Therapies Versus Placebo
or Management Without Pharmacologic
Therapies
The evidence … and individual treatments. … The response to antibiotic therapy as well as
corticosteroid therapy in ECOPD likely differs
based … therapy versus placebo
in ECOPD,48 but identification of responders to
systemic corticosteroid treatment
-
www.ahrq.gov/sites/default/files/2024-12/doucette-report.pdf
January 01, 2024 - We
evaluated interventions for MTM by randomizing pharmacies and patients into two treatment
groups … Both treatment groups received automated targeted interventions and
a patient engagement intervention … One treatment group also received pharmacist training. … intended to
improve drug therapy for Medicare beneficiaries. … Clinical
Therapeutics. 2013 Mar; 35(3):344-350.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - Third, CKD may be a marker for
individuals less likely to receive proven medical therapies. … individuals with a myocardial infarction, those with CKD are less likely to receive proven
effective therapies … associated underlying conditions or
cardiovascular risk factors, such as hypertension or diabetes,21 with therapeutic … Treatments may be CKD-
specific or non-specific. … treatments and kidney disease.
-
www.ahrq.gov/research/findings/final-reports/crctoolkit/crctoolkit3.html
April 01, 2018 - that patients understand that this is a focus group for an intervention and not part of a support or therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Adherence
to long-term therapies. … Wirelessly observed therapy in
comparison to directly observed therapy for the
treatment of tuberculosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
October 30, 2019 - predicting stroke and
bleeding risk in persons with AFib, and
comparative effectiveness of a variety of therapies … The “as
treated” (treatment received)
analysis compares the actually
received treatments. … do not seem like clear labels,
since both are active treatments. … We have separated the tables
out as to whether the patients
are on therapy or not, the
specific therapies … We have expanded this section
to include information on the
various treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
March 16, 2017 - eligible for a defined Medicare benefit category, 2) be reasonable
and necessary for the diagnosis or treatment … community ambulator who has the ability to traverse most environmental barriers
and may have vocational, therapeutic … vascular dysfunction, skin ulceration/damage, visual
dysfunction, peripheral neuropathy, local cancer treatment … of amputation
o Time since amputation
o Comorbidities (e.g., diabetes, CVD, PVD)
o Operative treatment … “Preservation-Amputation Care and Treatment (PACT)
Program.” In: Affairs DoV, editor.
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
February 01, 2016 - Comparisons were of an included
therapy versus placebo (drug trials), sham treatments
(nonpharmacological … Nonpharmacological treatments versus sham, no treatment, or usual care for acute or subacute low back … , which could attenuate
treatment benefits if suboptimal treatment techniques
or intensity of therapy … In addition,
a number of nonpharmacological therapies (e.g.,
psychological therapies, exercise therapy … Therapeutic aquatic exercise in the
treatment of low back pain: a systematic review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
March 01, 2010 - Because of concern that some patients might receive H-ISDN late in their illness as a
salvage treatment … for very severe HF that had proven refractory to other
treatments. … A
comparison of enalapril with hydralazine-
isosorbide dinitrate in the treatment of
chronic congestive … A review of uses of
health care utilization databases for
epidemiologic research on therapeutics. … Mortality hazard ratios for receipt of selected heart failure therapies or combinations versus no therapy
-
www.ahrq.gov/sites/default/files/2024-02/zierler-report.pdf
January 01, 2024 - The
clinical tools include treatment and prevention guidelines, provider order sets, risk assessment … and who were discharged with appropriate outpatient therapy.
5. … The VTE Safety Toolkit consists of diagnostic, preventive, and
therapeutic algorithms as well as a mandatory … Improve the treatment of VTE once it occurs, both in hospital and after discharge. … for VTE, and patient education for VTE
prevention and treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - are the timeframe (induction and
latent periods), changes in exposure status or exposure to other therapies … Similarly,
in a comparative evaluation of cognitive behavioral
therapy (CBT) for treatment of depression … questions for the same chronic
condition may use different approaches to
measuring exposure to the treatments … When using data outside of the United States,
the World Health Organization’s Anatomical
Therapeutic … Exposure to Multiple Therapies
A complexity in observational CER is the
lack of control over other
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
April 28, 2010 - (e.g., referred for specialty treatment). … Treatments for alcohol dependence
• Cognitive behavioral therapy
• Motivational enhancement therapy … It is possible that the assessments of alcohol misuse
conducted in the included trials conceal therapeutic … RCT of
effectiveness of motivational enhancement therapy delivered by
nurses for hazardous drinkers … Assessment may conceal
therapeutic benefit: findings from a randomized controlled trial for
hazardous